Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intuitive Surgical, Inc. (ISRG) vs T Rowe Price Group Inc (TROW) Price & Performance

Intuitive Surgical, Inc.Trade
T Rowe Price Group IncTrade

Price performance (Past 24H)

Key statistics

Intuitive Surgical, Inc. vs T Rowe Price Group Inc — how do they compare? Intuitive Surgical, Inc. trades at $419.76 (market cap $146.76B), while T Rowe Price Group Inc trades at $104.6 (market cap $22.23B). The key difference: Intuitive Surgical, Inc. is far larger — about 6.6× T Rowe Price Group Inc's market cap, and T Rowe Price Group Inc pays a 4.99% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and T Rowe Price Group Inc for 115 Days on average.

ISRGTROW
Market Cap
$146.76B$22.23B
Volume
2,529,8142,834,949
Sector
HealthFinancials
52-Week High
$592.85$121.68
52-Week Low
$332.02$86.19
Typical Hold Time
84 Days115 Days
Enterprise Value
$141.54B$19.43B
Dividend Yield
—4.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $414.52, up 2.41% today, with strong bullish technical signals from moving averages. The company demonstrates robust fundamentals with revenue growth from $6.2B in 2022 to $10.1B in 2025 and net income margin expanding to 28.45%. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast.

ISRG maintains a dominant position in robotic surgery with expanding international growth, though valuation multiples remain elevated with a P/E of 47.64. Analyst consensus is strongly bullish with a $480.78 price target representing 16% upside potential. Key risks include competitive pressures and international market volatility, particularly in China.

T Rowe Price Group Inc

T. Rowe Price Group (TROW) trades at $104.07, showing modest daily gains of 0.45%. The stock presents mixed signals with bearish technical indicators but strong fundamentals including a low P/E of 10.46 and robust profitability metrics. Recent earnings show two consecutive beats, with Q3 2026 results pending. The company maintains solid cash flow generation and recently announced a $1.30 dividend payment for September 2026, continuing its 40-year dividend growth streak.

TROW offers value characteristics with attractive valuation multiples and consistent dividend growth, though technical weakness and mixed analyst sentiment suggest near-term caution. Upside potential exists to the $112 consensus target, but investors face risks from market-sensitive revenue streams and ongoing net outflows despite AUM growth to $1.90 trillion as of August 2026.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ISRG
25% Buy75% Sell
Avg holding period · 84 Days
TROW

No sentiment data available yet.

Top news

Latest headlines on both assets

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →

About T Rowe Price Group Inc

T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.

Read more on TROW →